FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc. under ANDA076690.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder
• Panic Disorder
• Social Anxiety Disorder

Drugs mentioned

• Venlafaxine hydrochloride (Venlafaxine hydrochloride)

Snippet

SUPPL AP for VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE)